Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
includes Multisystem Inflammatory Syndrome
32267081 2020. Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome
32267072 2020. IV anakinra for macrophage activation syndrome may hold lessons for treatment of cytokine storm in the setting of COVID19
32340759 ä. Inappropriate Antibiotic Consumption as a Possible Cause of Inflammatory Storm and Septic Shock in Patients Diagnosed with Coronavirus Disease 2019 (COVID-19)
32251717 ä. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
32145275 2020. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
32348783 2020. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis
32202240 2020. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
32301997 ä. Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients
32325025 ä. COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
32334118 ä. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019
| 32360286 2020. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 |
32311489 ä. Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection
| 32205092 ä. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib |
32194247 ä. Exuberant Plasmocytosis in Bronchoalveolar Lavage Specimen of the First Patient Requiring Extracorporeal Membrane Oxygenation for SARS-CoV-2 in Europe
32353251 ä. COVID-19 cytokine storm: the interplay between inflammation and coagulation
32339596 ä. Predictive factors of poor outcomes in the COVID-19 epidemic: Consider the inflammatory response
32249847 ä. In the eye of the COVID-19 cytokine storm
32226636 2020. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
32298458 2020. Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis?
32238976 2020. Cytokinstormer ved covid-19?
32321221 2020. Hemofagocytisk lymfohistiocytose ved covid-19?
32125642 ä. Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
32397174 2020. Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity.
| 32376400 ä. Cytokine storm syndrome in severe COVID-19 |
| 32376401 ä. Fatal COVID-19 infections: Is NK cell dysfunction a link with autoimmune HLH? |
32293098 2020. On the Alert for Cytokine Storm: Immunopathology in COVID-19
32339387 2020. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin
32345602 2020. Covid-19: concerns grow over inflammatory syndrome emerging in children
32217834 2020. SARS-CoV-2: a storm is raging.
32343429 2020. Elevated Interleukin-6 and Severe COVID-19: A Meta-Analysis
32192578 2020. COVID-19: consider cytokine storm syndromes and immunosuppression
32303591 2020. Cytokine release syndrome in severe COVID-19
32114747 2020. Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies
32393680 2020. Incomplete Kawasaki Disease in a Child with Covid-19.
32387470 2020. COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
| 32418715 ä. COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons |
32388462 2020. A glimpse into the eye of the COVID-19 cytokine storm
| 27925643 2017. Primary and secondary hemophagocytic lymphohistiocytosis have different patterns of T?cell activation, differentiation and repertoire |
32462467 2020. Covid-19 and Kawasaki Disease: A Glimpse at the Past for a Predictable Future.
32423585 2020. Is the HScore useful in COVID-19? index of hyperinflammation
C7108005 ä. Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients
32463092 2020. Multisystem Inflammatory Syndrome in Children during the COVID-19 pandemic: a case series.
32441749 2020. COVID-19 Associated Pediatric Multi-System Inflammatory Syndrome.
32511692 2020. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
| 32504757 2020. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications. |
32423291 2020. Association Between COVID-19 and Kawasaki Disease: Vigilance Required From Otolaryngologists.
32511676 2020. Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City.
32511667 2020. SARS-CoV-2-Related Inflammatory Multisystem Syndrome in Children: Different or Shared Etiology and Pathophysiology as Kawasaki Disease?
32467454 2020. Covid-19 and Kawasaki Disease: An Etiology or Coincidental Infection?
32493739 2020. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study.
32401447 2020. Quels liens entre le SARS-CoV-2 et la maladie de Kawasaki ?
| 32492695 2020. Does the newly observed inflammatory syndrome in children demonstrate a link between uncontrolled neutrophil extracellular traps formation and COVID-19? |
32439816 2020. SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children.
32393592 2020. Cytokine storm and the prospects for immunotherapy with COVID-19.
32493734 2020. New spectrum of COVID-19 manifestations in children: Kawasaki-like syndrome and hyperinflammatory response.
32505742 2020. Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children (MIS-C) that is related to COVID-19: a single center experience of 44 cases. Henoch Schoenlein-related
32455505 2020. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.
32508068 2020. Defining Association between COVID-19 and the Multisystem Inflammatory Syndrome in Children through the Pandemic.
32412405 2020. Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation.
32414749 2020. Covid-19: Cases of inflammatory syndrome in children surge after urgent alert.
32493704 2020. Pediatric inflammatory syndrome temporally related to covid-19.
32412400 2020. Covid-19 and Kawasaki syndrome: should we really be surprised?
32404331 2020. COVID-19 and Kawasaki Disease: Finding the Signal in the Noise.
32462354 2020. Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during COVID-19 Pandemic.
32468151 2020. The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm?
32397684 2020. SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment.
32476380 2020. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines.
32418446 2020. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic.
32456973 2020. The novel coronavirus (COVID-19) and the risk of Kawasaki disease in children.
32399895 2020. Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19.
32385146 2020. The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response.
32283152 2020. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.
32525700 2020. Multi-System Inflammatory Syndrome in Children in Association with COVID-19.
32452979 2020. Pediatric Crohn's Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated with Infliximab.
32474885 2020. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
32474804 2020. Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
32468178 2020. Reply to the letter by Gaetano Loscocco, Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
32460624 2020. The amount of cytokine-release defines different shades of Sars-Cov2 infection.
